Clinical Trial Update: Marker of Brain Insulin Resistance in AD Prognosis [NA]

View source ↗

Summary

A clinical trial in France is evaluating brain insulin resistance as a prognostic biomarker for Alzheimer's disease and mild cognitive impairment; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Prognosis Biomarker of AD, Mild Cognitive Impairment | NA | Status: NOT_YET_RECRUITING